Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Diabetes mellitus is a chronic condition that requires complex management; however, the time of health care providers is limited and patient motivation varies. How can health care providers design realistic treatment plans and establish priorities that maximize health benefits for patients? The 2008
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 5×
“Only 40% of Americans with diabetes meet the blood pressure target of less than 130/80 mm Hg.26 In the Steno-2 trial, 51% of patients had a systolic pressure of less than 130 mm Hg and 72% had a diastolic pressure less than 80 mm Hg.8 In that study, the difference in the proportion of patients at the target level betw…”
BackgroundMethodResultInfluentialTelmisartan, ramipril, or both in patients at high risk for vascular events
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801317 · Cited by 3,502
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Kinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
Kastelein, J. J. P., Akdim, F., Stroes, E. S. G., Zwinderman, A. H., Bots, M. L., Stalenhoef, A. F. H., Visseren, F. L. J., Sijbrands, E. J. G., Trip, M. D., Stein, E. A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800742 · Cited by 1,241 · cited 1×
“A recent study of the benefit of adding ezetimibe to statins for patients with familial hypercholesterolemia failed to show any benefit; thus, the role of combination therapy remains unclear.(32,33) Statins are well tolerated and well-studied medications whose benefits largely outweigh the risks.”
BackgroundBobrie, G. (2004) · JAMA · doi:10.1001/jama.291.11.1342 · Cited by 842 · cited 1×
“Furthermore, several studies have suggested that home blood pressure values are more predictive of mortality than blood pressure readings taken at office visits.(29,30)”
BackgroundStatin Safety: A Systematic Review
Law, M., & Rudnicka, A. R. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.010 · Cited by 808 · cited 3×
“More severe adverse outcomes are rare: reversible myopathy (1 in 9100/year), rhabdomyolysis (1 in 29 000/year) and liver failure (1 in 200 000/year).(35) However, the rate of liver failure in patients taking statins is similar to the rate in the general population.”
BackgroundInfluentialChurch, T. S., LaMonte, M. J., Barlow, C. E., & Blair, S. N. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.18.2114 · Cited by 445
Physical activity and risk for cardiovascular events in diabetic women
Hu, F. B., Stampfer, M. J., Solomon, C., Liu, S., Colditz, G. A., Speizer, F. E., Willett, W. C., & Manson, J. E. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-2-200101160-00009 · Cited by 424
Cited by
Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk
Chia, C. W., Egan, J. M., & Ferrucci, L. (2018) · Circulation Research · doi:10.1161/circresaha.118.312806 · Cited by 454
De Berardis, G., Sacco, M., Strippoli, G. F. M., Pellegrini, F., Graziano, G., Tognoni, G., & Nicolucci, A. (2009) · BMJ · doi:10.1136/bmj.b4531 · Cited by 395
“Aspirin is recommended by key guideline agencies for the primary prevention of cardiovascular events in people with diabetes, although with some inconsistencies (see web extra on bmj.com).”
Effects of Exercise on Cardiovascular Risk Factors in Type 2 Diabetes
Chudyk, A., & Petrella, R. J. (2011) · Diabetes Care · doi:10.2337/dc10-1881 · Cited by 331
“CVD is the leading cause of mortality among individuals with diabetes (7,8), accounting for 65% of all deaths among this patient group (9).”
BackgroundLabarga, P., Barreiro, P., Martin-Carbonero, L., Rodriguez-Novoa, S., Solera, C., Medrano, J., Rivas, P., Albalater, M., Blanco, F., Moreno, V., et al. (2009) · AIDS · doi:10.1097/qad.0b013e3283262a64 · Cited by 294
Metadata
- Authors
- Bhattacharyya, O. K., Shah, B. R., & Booth, G. L.
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Joule Inc.
- Published
- 2008-10-21
- Volume
- 179
- Issue
- 9
- Pages
- 920-926
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- OpenAlex
- W2075388377
- Cited by
- 52
- References
- 17
- FWCI
- 3.70
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines. https://app.cochat.ai/papers/10.1503/cmaj.080554
- The paper
- Bhattacharyya, O. K., Shah, B. R., & Booth, G. L. (2008). Management of cardiovascular disease in patients with diabetes: the 2008 Canadian Diabetes Association guidelines. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.080554
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.